Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase NA 2Phase 2 2Phase 4 1

Status

Completed 21Unknown 5Terminated 2Withdrawn 1Suspended 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Other 1Gynecologic 1

Conditions

Breast Neoplasms 145Carcinoma, Non-Small-Cell Lung 97Colorectal Neoplasms 96Carcinoma, Hepatocellular 69Stomach Neoplasms 65Rectal Neoplasms 54Neoplasms 53Lung Neoplasms 44Prostatic Neoplasms 41Colonic Neoplasms 41Leukemia, Myeloid, Acute 40Nasopharyngeal Carcinoma 39Lymphoma, Large B-Cell, Diffuse 39Uterine Cervical Neoplasms 37Esophageal Neoplasms 33Ovarian Neoplasms 32Neoplasm Metastasis 32Multiple Myeloma 31Lymphoma 31Lymphoma, Follicular 30Leukemia 28Pancreatic Neoplasms 27Recurrence 23Head and Neck Neoplasms 22Brain Neoplasms 21Urinary Bladder Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, Non-Hodgkin 19Lymphoma, Mantle-Cell 18Squamous Cell Carcinoma of Head and Neck 17

Interventions

Sodium Chloride 2Paclitaxel 2Carboplatin 2Taxes 1Saline Solution 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Neurotoxicity Syndromes × Clear all
NCT00660842 2023-03-24

MITO-7

National Cancer Institute, Naples

Phase 3 Unknown
800 enrolled
Gynecologic

Ovarian Neoplasms, Neurotoxicity Syndromes

NCT00807768 2019-03-20

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

GOG Foundation

Phase 3 Unknown
601 enrolled 13 charts
Other

Fatigue, Obesity, Neurotoxicity Syndromes

NCT01882621 2016-06-01

Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients

Sun Yat-sen University

Phase 3 Unknown
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neurotoxicity Syndromes

NCT02024412 2015-09-28

Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRC

Tianjin Medical University Cancer Institute and Hospital

Phase 3 Unknown
240 enrolled
Gastrointestinal

Colorectal Neoplasms, Neurotoxicity Syndromes

NCT02024438 2015-09-28

Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 3 Unknown
240 enrolled
Gastrointestinal

Stomach Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡